Status:
COMPLETED
Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia
Lead Sponsor:
Istanbul Nisantasi University
Conditions:
Corona Virus Infection
Thromboembolic Disease
Eligibility:
All Genders
18-99 years
Brief Summary
Covid-19 mainly affects the respiratory system. Multiple organ dysfunction and a particularly progressive respiratory insufficiency along with a widespread coagulopathy presumed to be due to infection...
Detailed Description
The severe acute respiratory distress syndrome related coronavirus-2 (SARS-CoV-2) and its clinical presentation as Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, Hubei, China in Dece...
Eligibility Criteria
Inclusion
- patients diagnosed with COVID - 19 pneumonia between March 11 th , 2020 and April 25th, 2020 in the emergency, internal medicine and cardiology outpatient clinics.
- patients diagnosed by pcr testing and computed tomography of the chest
Exclusion
- patients below 18 years of age
- patients with an alternative aetiology of pneumonia
Key Trial Info
Start Date :
June 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 20 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04423315
Start Date
June 8 2020
End Date
July 20 2020
Last Update
September 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vital Hospital
Bahçelievler, Istanbul, Turkey (Türkiye), 34230